TransMedics Raises $36 Million
TransMedics Inc., an Andover, Mass.-based developer of portable life support systems for organ transplants, has raised $36 million in Series E funding. Foundation Capital and Kleiner Perkins Caufield co-led the round, and were joined by return backer Flagship Ventures. In December 2008, the company canceled an $86.25 million IPO, citing "market conditions." At the time, it had raised around $90 million in total VC funding, from firms like 3i Group (24.4% stake), Tudor Investment Corp. (14.7%), Flagship Ventures (14.3%), VantagePoint Venture Partners (10%), Sherbrooke Partners (9.2%), Alta Partners (8.9%), CB Health Ventures (7.4%), Posco BioVentures and Sagamore Bioventures.
4 March 2010•3 mins read
